Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Tetrafluoroethane BP EP USP Pharma Grade surfaces in pharmaceutical, industrial, and research contexts. This compound, known for a molecular formula of C2H2F4, has earned its place for purity and stability. With its roots as a hydrofluorocarbon, it sidesteps ozone depletion, contrasting with chlorofluorocarbons from decades past that caused global headlines for environmental harm. Manufacturers meet pharmaceutical benchmarks laid out in the British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP), tapping into this grade for aerosols, propellants, and some advanced drug delivery systems.
Colorless and nontoxic at moderate levels, the liquid shape of tetrafluoroethane displays low odor and evaporates at room temperature. Its density stands around 1.21 g/cm³ in liquid form at 25°C. This chemical material resists ignition, with an autoignition temperature reaching about 770°C, reducing the likelihood of accidental burning, yet that alone does not downplay proper storage. Volatility means it shifts between liquid and vapor swiftly under everyday pressure changes—a property crucial for metering precise doses in pressurized containers. Tetrafluoroethane appears neither as a powder nor flakes under standard conditions, instead showing up as a liquid or compressed gas. In a pure form, crystals do not occur except at very low temperatures, where the freezing point hovers at -101°C. This property can catch labs off guard if they expect easy handling at cold storage conditions. Its critical temperature sits near 101°C, connecting this data to the need for reinforced tanks and containers.
Each molecule shows a symmetric, tetrahedral shape at the atomic level: two carbon atoms, joined together, each cradled by fluorine and hydrogen atoms. Fluorine’s influence gives the compound distinct chemical resistance, helping it resist reaction with water and most acids, but hydrofluoric acid still demands sharp caution. This arrangement creates a strong dipole and allows it to stay stable over months, even in harsh pharmaceutical processing. The same molecular rigidity helps maintain dosage accuracy in metered applications. Boiling point lands at -26.3°C, so containers kept at room temperature will readily fill with vapor. The molecule brings nonreactivity to most cases but interacts aggressively with reactive metals like sodium or potassium—a risk often ignored outside experienced chemical storage teams.
Regulatory filings pin Tetrafluoroethane BP EP USP Pharma Grade to rigorous specifications. Purity levels reach 99.5% and higher, with moisture capped at under 10 ppm. Packaging requires inert gas in headspace and stainless steel vessels. Trace compounds, including hydrochlorofluorocarbons and other halogens, show up on batch certificates. Harmonized System (HS) Code for international trade commonly cites 2903 39 20 for tetrafluoroethanes within the hydrofluorocarbons product group. Each shipment requires strict temperature tracking, highlighting global safety rules that came into play after supply chain accidents. Researchers keep close to supplier documentation, especially if the product forms any part of the active pharmaceutical manufacturing pipeline.
End-users rarely face tetrafluoroethane outside pressurized cylinders, though large-scale industrial operations sometimes handle it as a supercooled liquid. Storage asks for pressurized, sealed cylinders—never glass or brittle plastics. Spillage routes straight to rapid vaporization, risking asphyxiation in small rooms. No pearls, flakes, or solid chunks are found under practical pharma conditions, which simplifies process planning but also calls for pressure-rated regulators and leak detection during bottle changes. Most pharmaceutical processes use the liquid extracted under pressure, vaporizing into the receiving system. Volumes measured in liters translate to hundreds of grams of gas, and any miscalculation directly complicates dose outcomes in finished products.
On paper, tetrafluoroethane delivers low toxicity, so chemical exposure limits in the range of 1,000 ppm come from decades of worker monitoring. But inhalation can rapidly displace oxygen in closed environments, and chronic exposure hints at nervous system side effects over years of handling. Steam-pressurized leaks create ice-cold jets that can freeze skin instantly—personnel training closes the risks, not regulation changes. The compound, while nonflammable under most lab conditions, can react at high temperatures to generate toxic fluorinated byproducts, especially if combined with open flames or strong reducing agents. Eye and skin contact call for rapid water rinse and medical follow-up. Proper ventilation, functional leak alarms, and real-time oxygen monitors add layers of security for daily handlers, and experience suggests skimping on training or maintenance becomes the true hazard, not just the chemical itself.
Upstream, producers use fluorspar, hydrogen fluoride, and ethylene as the raw material inputs. Care in sourcing, especially for pharmaceutical use, must eliminate trace impurities—lead, mercury, and arsenic testing shows up in every responsible supplier’s test reports due to heightened regulatory scrutiny. Batch records attach to each shipment and any deviation from the certified specification leads to recalls or rework. Those who use tetrafluoroethane in inhalers or surgical sprays trust only certified raw materials, given past contamination scandals in broader chemical industries. Pharmaceutical manufacturers, who cannot tolerate uncertainty in molecular identity or purity, demand transparent quality audits at every step.
Tetrafluoroethane does not harm the ozone, yet its global warming potential still lands high—over 1,000 times that of carbon dioxide over a hundred years. Regulatory changes have nudged the chemical sector towards tighter recycling, leak-proof storage, and recovery from expired or defective products. Recycling systems reclaim vapor for new manufacturing instead of venting to the air, but not every facility invests in these upgrades. Real environmental progress arrives when companies prioritize closed-loop handling and careful monitoring, joining international protocols aimed at shrinking the overall climate impact. From a practical angle, the solution grows from leadership willing to move beyond compliance and see the wider picture—future generations sit downstream from every ton of chemical managed today.
Chengguan District, Lanzhou, Gansu, China
